Research location
Brooklyn
Maryland, United States
Advertisement
Research activity in Brooklyn
Maryland, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 15 trials and 15 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Brooklyn
15 linked trials · page 1 of 1A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy ParticipantsNCT07723833 · 2026-07-27 · 1 site observation
RECRUITING
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.NCT07511205 · 2026-03-30 · 1 site observation
RECRUITING
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or ObesityNCT07013643 · 2025-06-04 · 1 site observation
RECRUITING
A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy ParticipantsNCT07534592 · 2026-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy ParticipantsNCT06948747 · 2025-05-06 · 1 site observation
COMPLETED
A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluoroolefin (HFO) Propellant Metered Dose Inhaler (MDI) Compared to a Hydrofluoroalkane (HFA) Propellant MDI in Healthy AdultsNCT06723756 · 2025-01-23 · 1 site observation
COMPLETED
A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy ParticipantsNCT06555822 · 2024-08-15 · 1 site observation
COMPLETED
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or ObeseNCT06132841 · 2023-11-13 · 1 site observation
COMPLETED
A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy VolunteersNCT06103877 · 2023-11-01 · 1 site observation
COMPLETED
Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or ObeseNCT05511025 · 2022-09-20 · 1 site observation
COMPLETED
A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers.NCT05457270 · 2022-08-11 · 1 site observation
COMPLETED
Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA PropellantNCT05477108 · 2022-07-29 · 1 site observation
COMPLETED
A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and DigoxinNCT05395117 · 2022-06-30 · 1 site observation
COMPLETED
Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427NCT04630067 · 2020-11-17 · 1 site observation
COMPLETED
To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With DyslipidemiaNCT04155645 · 2019-11-21 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.